You are here
Exosome Research Products Market by Product and Services - Global Forecast to 2024
DUBLIN, March 26, 2019 /PRNewswire/ -- The "Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market
The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period.
Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market to a certain extent in the coming years.
The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period
Based on end user, the exosomes research products market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to significant investments by companies in research activities for the development of exosome-based diagnostics to combat new diseases.
The lung cancer segment accounted for the largest share of the exosome research products market during the forecast period
Based on cancer applications, the exosomes research products market is segmented into lung, prostate, breast, colorectal, and other cancers. In 2018, lung cancer accounted for the largest share of the exosomes market for cancer applications. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies.
North America to dominate the market during the forecast period
In 2018, North America accounted for the largest share of the exosome research products market. The North American market is also expected to grow at the highest CAGR during the forecast period. Factors such as the availability of government funding for life science research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research are driving the growth of the exosomes market in North America.
According to R&D Magazine (2018), North America accounted for 27.36% of global R&D spending. North America has several national institutes that support biotechnology and life science research activities. The growth of the biotechnology and pharmaceutical industries and growth in the number of cancer cases in the region are also supporting market growth.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Exosomes Market: Overview
4.2 Exosomes Market, By Application, 2019-2024 (USD Million)
4.3 Exosome Market Share, By Cancer Applications & Region (2018)
4.4 Exosome Market, By End User, 2019 vs. 2024 (USD Million)
4.5 Exosome Market: Geographic Growth Opportunities
5 Market Overview
5.2 Market Dynamics
220.127.116.11 Increasing Funding for Life Sciences Research
18.104.22.168 High Global Prevalence of Cancer
22.214.171.124 Increasing Interest in Exosome-Based Procedures
126.96.36.199 Lack of Skilled Professionals
188.8.131.52 Untapped Emerging Markets
184.108.40.206 Growing Interest in Exosome-Based Therapeutics
220.127.116.11 Personalized Medicine
6 Exosomes Market, By Product & Service
6.2 Kits and Reagents
6.2.1 Kits and Reagents Segment to Witness the Highest Growth in the Exosomes Market During the Forecast Period
6.3.1 Increase in the Number of Diagnostic Laboratories Offering Exosome-Based Tests to Drive the Adoption of Instruments
6.4.1 Exosome Services Aid Oncologists to Detect and Monitor Cancer Biomarkers From A Simple Blood Or Urine Sample
7 Exosomes Market, By Application
7.2 Cancer Applications
7.2.1 Lung Cancer
18.104.22.168 Increasing Prevalence of Lung Cancer and Technological Advancements in Instruments & Assays for Liquid Biopsy to Drive Market Growth
7.2.2 Breast Cancer
22.214.171.124 High Prevalence of Breast Cancer and Increasing Awareness to Drive the Market for This Segment
7.2.3 Prostate Cancer
126.96.36.199 Liquid Biopsy Helps Detect Aggressive Prostate Cancer Before SurgeryA Key Factor Driving Market Growth
7.2.4 Colorectal Cancer
188.8.131.52 Increasing Research Activities and Projects Based on Exosomes to Drive the Market for This Segment
7.2.5 Other Cancers
184.108.40.206 Rising Incidence of Cancer and Increasing Research Funding to Drive the Market for This Segment
7.3 Non-Cancer Applications
7.3.1 Wide Range of Non-Cancer Applications to Drive Growth in the Demand for Exosomes in This Application Segment
8 Exosomes Market, By End User
8.2 Academic & Research Institutes
8.2.1 Academic & Research Institutes are the Largest End Users in the Exosomes Market
8.3 Pharmaceutical & Biotechnology Companies
8.3.1 Significant Developments in Research Activities to Drive Market Growth in This End-User Segment
8.4 Hospitals & Clinical Testing Laboratories
8.4.1 Hospitals & Clinical Testing Laboratories Use Exosomes for the Diagnosis of Cancer
9 Exosomes Market, By Region
9.2 North America
220.127.116.11 High Burden of Cancer and Favorable Public and Private Funding for Research Activities to Drive Market Growth
18.104.22.168 Availability of Research Funding & Rising Incidence of Cancer to Drive Market Growth
22.214.171.124 Presence of A Large Number of Academic Research Institutes to Support Market Growth
126.96.36.199 Growth in the Life Sciences Industry to Drive the Market for Exosomes in the UK
188.8.131.52 Government Initiatives to Boost R&D Activities in the Country and High Healthcare Expenditure are the Key Factors Driving Market Growth
184.108.40.206 Government Initiatives to Strengthen the Biotechnology Industry and the High Prevalence of Cancer are the Major Factors Driving Market Growth
220.127.116.11 High Prevalence of Cancer and Increasing Healthcare Expenditure are the Key Drivers for the Exosomes Market in the Country
9.4.3 Rest of Asia
9.5 Rest of the World
10 Competitive Landscape
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Partnerships and Agreements (2016-2019)
10.3.2 Product Launches (2016-2019)
10.3.3 Acquisitions (2016-2019)
10.3.4 Expansions (2016-2019)
10.4 Competitive Leadership Mapping (2017)
10.4.3 Dynamic Players
10.4.4 Emerging Players
11 Company Profiles
11.2 Thermo Fisher Scientific Inc.
11.3 System Biosciences (SBI)
11.4 NX Pharmagen
11.5 Qiagen N.V.
11.6 Miltenyi Biotech
11.7 AMS Biotechnology Ltd.
11.9 Lonza Group AG
11.10 Norgen Biotek Corp.
For more information about this report visit https://www.researchandmarkets.com/research/dw957m/exosome_research?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets